DorsaVi Ltd (ASX: DVL) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

DorsaVi Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.58 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 731.24 million
Earnings per share -0.002
Dividend per share N/A
Year To Date Return -25.00%
Earnings Yield N/A
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

DorsaVi Ltd (ASX: DVL)
Latest News

a woman
Investing

Will Dorsavi Ltd be the next Catapult Group International Ltd?

Dorsavi Ltd (ASX:DVL) sports some exciting potential.

Read more »

a woman
Investing

Are these the last 3 cheap stocks on the ASX?

It might be time value investors took a closer look at Reject Shop Ltd (ASX:TRS), INGENIA STAPLED (ASX:INA) and Dorsavi…

Read more »

DVL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About DorsaVi Ltd

DorsaVi Ltd is engaged in the development and sale of motion analysis technologies. Its technologies are commercialized via license, sale, or fixed-fee consultancy. The company makes wearable sensors, software, and sophisticated algorithmsthat measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), and others. The firm operates in two reportable segments: Clinical, and Workplace. A majority of its revenue is generated from the Clinical segment. Geographically, the company derives maximum revenue from the United States of America, and the rest from Australia, and Europe.

DVL Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
09 May 2025 $0.01 $0.00 0.00% 786,501 $0.01 $0.01 $0.01
08 May 2025 $0.01 $0.00 0.00% 63,881 $0.01 $0.01 $0.01
07 May 2025 $0.01 $0.00 0.00% 324,964 $0.01 $0.01 $0.01
06 May 2025 $0.01 $0.00 0.00% 1,246,953 $0.01 $0.01 $0.01
05 May 2025 $0.01 $0.00 0.00% 1 $0.01 $0.01 $0.01
02 May 2025 $0.01 $0.00 0.00% 1 $0.01 $0.01 $0.01
30 Apr 2025 $0.01 $0.00 0.00% 1 $0.01 $0.01 $0.01
29 Apr 2025 $0.01 $0.00 0.00% 105,614 $0.01 $0.01 $0.01
28 Apr 2025 $0.01 $0.00 0.00% 255,195 $0.01 $0.01 $0.01
24 Apr 2025 $0.01 $0.00 0.00% 393,234 $0.01 $0.01 $0.01
23 Apr 2025 $0.01 $0.00 0.00% 677,220 $0.01 $0.01 $0.01
22 Apr 2025 $0.01 $0.00 0.00% 1 $0.01 $0.01 $0.01
17 Apr 2025 $0.01 $0.00 0.00% 977,415 $0.01 $0.01 $0.01
15 Apr 2025 $0.01 $0.00 0.00% 1 $0.01 $0.01 $0.01
14 Apr 2025 $0.01 $0.00 0.00% 1 $0.01 $0.01 $0.01

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
15 Nov 2024 Gernot Abl Issued 1,619,821 $18,951
Director remuneration.
15 Nov 2024 Gernot Abl Issued 4,545,454 $54,545
Placement.
15 Nov 2024 Gernot Abl Issued 4,545,454 $49,999
Placement.
15 Nov 2024 Andrew Ronchi Issued 3,636,363 $39,999
Placement.
15 Nov 2024 Andrew Ronchi Issued 4,045,561 $47,333
Director remuneration.
15 Nov 2024 Andrew Ronchi Issued 3,636,363 $43,636
Placement.
15 Nov 2024 Michael Winlo Issued 2,797,394 $32,729
Placement.
15 Nov 2024 Michael Winlo Issued 454,545 $5,454
Placement.
15 Nov 2024 Michael Winlo Issued 454,545 $4,999
Placement.
13 Jun 2024 Andrew Ronchi Issued 1,100,000 $13,200
Issue of securities.
13 Jun 2024 Andrew Ronchi Issued 1,000,000 $12,000
Issue of securities. 1,000,000 Performance Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Gernot Kurt Abl Non-Executive DirectorNon-Executive Chairman Mar 2024
Mr Abl is a public company director with a background in law, corporate finance, and management consulting and has more than 20 years of entrepreneurial, business strategy, and investment experience. Gernot has worked with many early-stage businesses, across industries, to help commercialise, grow, and increase the value of the business for all stakeholders. Gernot is also on the board of and advises several medium and high-growth businesses, ranging from early-stage pre-revenue companies through to early-stage ASX-listed companies.
Dr Andrew James Ronchi Chief Executive OfficerExecutive Director Feb 2008
Mr Ronchi was a practicing physiotherapist both at an AFL club and in private practice. He has also been founding partner in two physiotherapy centers, the largest of these employing 28 staff (including 13 physiotherapists).
Mr Leigh Daniel Travers Non-Executive Director Dec 2024
Mr Travers is currently the Director of Emerging Markets with Hong Kong-based web3 investment and incubation company Animoca Brands. Mr Travers was previously the CEO of Binance Australia from 2021 to mid-2023. Mr Travers has also been a Director and CEO of DigitalX Limited (ASX:DCC), He has spent his career in public markets, including as a Non-Executive Director for investment and technology companies on the NASDAQ and the TSX. In his professional career Mr Travers was also involved in several other technology related initiatives including: Championed the adoption of blockchain and the pathway for blockchain businesses as Director and Treasurer of Australias blockchain industry body. Provided technical, marketing and investor advisory services to multiple blockchain startups which went on to achieve unicorn status.
Dr Michael Winlo Non-Executive Director Oct 2023
Dr Winlo has a leadership experience across the biotechnology, pharmaceutical and technology sectors. He is currently Chief Executive Officer. Dr Winlo also serves as a director and former CEO of Linear Clinical Research, a world-class provider of early and late-stage pharmaceutical trial facilities and management services. Prior to his role at Linear, Dr Winlo was based in Silicon Valley for five years as the Health Lead at Palantir Technologies (NYSE: PLTR).
Mr Vineet Agarwal Non-Executive Director Sep 2024
Mr Agarwal has 18 years in the technology sector. Mr Agarwal is currently Product Management Director at Advanced Micro Devices (NASDAQ:AMD), where he has overseen management and product launch of the Ryzen Client Product line. Prior to AMD, Mr Agarwal held strategic roles at Qualcomm (NASDAQ:QCOM), including Director of Program Management and Senior Manager, driving the development of QCOMs Snapdragon platform.
Mr Justin Mouchacca Company Secretary Sep 2023
-
Justin Mouchacca Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Mr Bilal Ahmad 53,500,000 7.99%
Mrs Ifrah Nishat 50,027,271 7.48%
Starfish Technology Fund II Nominees A Pty Ltd 48,763,230 7.29%
Starfish Technology Fund II Nominees B Pty Ltd 48,763,229 7.29%
Miss Ifrah Nishat 40,034,955 5.98%
Vesparum Group Investments Pty Ltd 23,511,311 3.51%
Ms Chunyan Niu 23,455,438 3.51%
Mr Bin Liu 17,958,568 2.68%
David Dominic Pevcic 16,545,454 2.47%
Kobala Investments Pty Ltd Fernando Edward Family A/C 16,409,090 2.45%
Valence Holdings Pty Ltd the PW & CM Stinton Superannuation Fund A/C 15,277,779 2.28%
Tanarny Super Fund Pty Ltd Tanarny Super Fund A/C 14,209,132 2.12%
Ddpevcic (WA) Pty Ltd (Dominic Family A/C) 12,590,909 1.88%
Hall Capital Finance Pty Ltd Phoenix Microcap A/C 11,916,942 1.78%
449 Investments Pty ltd the A&R Hynes Family S/F A/C 9,791,667 1.46%
AR BSM Pty Ltd AR BSM A/C 8,706,965 1.30%
Dr Zonair Ikram 8,352,903 1.25%
Mr Salvatore Di Vincenzo 8,087,189 1.21%
Mr Dean Brett Blankfield Dean Blankfield A/C 6,636,363 0.99%
Creative Hindsight Pty Ltd 6,360,871 0.95%

Profile

since

Note